Cite
HARVARD Citation
Law, V. et al. (2022). A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma. Neuro-oncology. 24 (10), pp. 1673-1686. [Online].